Differentiation rather than aging of muscle stem cells abolishes their telomerase activity

Biotechnology Progress

Volumn 25, Issue 4, 2009, Pages 1130-1137

  O'Connor, Matthew S ^a   Carlson, Morgan E ^a   Conboy, Irina M ^a  

^a University of California at Berkeley   (United States)

Author keywords

Aging; Muscle; Myoblast; Satellite cell; Telomerase; Telomere; Tissue engineering

Indexed keywords

AGING; MYOBLAST; SATELLITE CELL; TELOMERASE; TELOMERE;

BIOLOGICAL SYSTEMS; CELL CULTURE; CELL MEMBRANES; CHROMOSOMES; NEURONS; REPAIR; SATELLITES; STRAIN; TISSUE ENGINEERING;

MUSCLE;

TELOMERASE;

AGING; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONFERENCE PAPER; CYTOLOGY; ENZYMOLOGY; MALE; METABOLISM; MOUSE; MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; TELOMERE;

AGING; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; MUSCLES; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELLS; TELOMERASE; TELOMERE;

MUS;

EID: 69149098364     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.223     Document Type: Conference Paper

References (57)

1. Schultz E, Gibson MC, Champion T. Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J. Exp. Zool. 1978; 206: 451-456.
2. Collins M, Renault V, Grobler LA, St Clair Gibson A, Lambert MI, Wayne Derman E, Butler-Browne GS, Noakes TD, Mouly V. Athletes with exercise-associated fatigue have abnormally short muscle DNA telomeres. Med. Sci. Sports Exerc. 2003; 5: 1524-1528.
3. Akbar AN, Vukmanovic-Stejic M. Telomerase in T lymphocytes: use it and lose it? J. Immunol. 2007; 178: 6689-6694.
4. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 1996; 5: 207-216.
5. Leedham SJ, Brittan M, McDonald SA, Wright NA. Intestinal stem cells. J. Cell. Mol. Med. 2005; 9: 11-24.
6. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 2005; 205: 147-157.
7. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum. Gene. Ther. 1997; 8: 1429-1438.
8. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 1996; 16: 2932-2939.
9. Wernig A, Schafer R, Knauf U, Mundegar RR, Zweyer M, Hogemeier O, Martens UM, Zimmermann S. On the regenerative capacity of human skeletal muscle. Artif. Organs 2005; 29: 192-198.
10. Wagers AJ, Conboy IM. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell. 2005; 122: 659-667.
11. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005; 433: 760-764.
12. Carlson ME, Conboy IM. Loss of stem cell regenerative capacity within aged niches. Aging Cell. 2007; 6: 371-382.
13. Goldspink G. Loss of muscle strength during aging studied at the gene level. Rejuvenation Res. 2007; 10: 397-405.
14. Negroni E, Butler-Browne GS, Mouly V. Myogenic stem cells: regeneration and cell therapy in human skeletal muscle. Pathol. Biol. (Paris) 2006; 54: 100-108.
15. Chakkalakal JV, Thompson J, Parks RJ, Jasmin BJ. Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. FASEB J. 2005; 19: 880-891.
16. Partridge T. Myoblast transplantation. Neuromuscul. Disord. 2002; 12 (Suppl 1): S3-S6.
17. El Fahime E, Torrente Y, Caron NJ, Bresolin MD, Tremblay JP. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp. Cell Res. 2000; 258: 279-287.
18. Yan W, George S, Fotadar U, Tyhovych N, Kamer A, Yost MJ, Price RL, Haggart CR, Holmes JW, Terracio L. Tissue engineering of skeletal muscle. Tissue Eng. 2007; 13: 2781-2790.
19. Boontheekul T, Hill EE, Kong HJ, Mooney DJ. Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng. 2007; 13: 1431-1442.
20. Beier JP, Kneser U, Stern-Strater J, Stark GB, Bach AD. Y chromosome detection of three-dimensional tissue-engineered skeletal muscle constructs in a syngeneic rat animal model. Cell Transplant. 2004; 13: 45-53.
21. Peault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, Gussoni E, Kunkel LM, Huard J. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther. 2007; 15: 867-877. (Pubitemid 46621645)
22. Conboy IM, Rando TA. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 2002; 3: 397-409.
23. Conboy MJ, Karasov AO, Rando TA. High incidence of nonrandom template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS Biol. 2007; 5: e102.
24. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, Morgan JE. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell. 2005; 122: 289-301.
25. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notch-mediated restoration of regenerative potential to aged muscle. Science. 2003; 302: 1575-1577.
26. Di Donna S, Renault V, Forestier C, Piron-Hamelin G, Thiesson D, Cooper RN, Ponsot E, Decary S, Amouri R, Hentati F, Butler-Browne GS, Mouly V. Regenerative capacity of human satellite cells: the mitotic clock in cell transplantation. Neurol. Sci. 2000; 21 (5 Suppl): S943-S951.
27. Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev. Biol. Anim. 1995; 31: 773-779.
28. Schultz E, McCormick KM. Skeletal muscle satellite cells. Rev. Physiol. Biochem. Pharmacol. 1994; 123: 213-257.
29. Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease. Genes Dev. 2006; 20: 1692-1708.
30. Carlson ME, Conboy IM. Loss of stem cell regenerative capacity within aged niches. Aging Cell 2007; 6: 371-382.
31. Kelly R, Alonso S, Tajbakhsh S, Cossu G, Buckingham M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J. Cell Biol. 1995; 129: 383-396.
32. Dhawan J, Rando TA. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 2005; 15: 666-673.
33. Buckingham M. Skeletal muscle progenitor cells and the role of Pax genes. CR. Biol. 2007; 330 (6-7): 530-533.
34. Collins CA. Satellite cell self-renewal. Curr. Opin. Pharmacol. 2006; 6: 301-306.
35. Castro P, Giri D, Lamb D, Ittmann M. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate. 2003; 55: 30-38.
36. Eisenhauer KM, Gerstein RM, Chiu CP, Conti M, Hsueh AJ. Telomerase activity in female and male rat germ cells undergoing meiosis and in early embryos. Biol. Reprod. 1997; 56: 1120-1125.
37. Fujisawa M, Tanaka H, Tatsumi N, Okada H, Arakawa S, Kamidono S. Telomerase activity in the testis of infertile patients with selected causes. Hum. Reprod. 1998; 13: 1476-1479.
38. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 2003; 16 (Pt 9): 1827-1835.
39. Herrera E, Samper E, Blasco MA. Telomere shortening in mTR-/-embryos is associated with failure to close the neural tube. EMBO J. 1999; 18: 1172-1181.
40. Martin-Rivera L, Herrera E, Albar JP, Blasco MA. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 1998; 95: 10471-10476.
41. Ravindranath N, Dalal R, Solomon B, Djakiew D, Dym M. Loss of telomerase activity during male germ cell differentiation. Endocrinology. 1997; 138: 4026-4029.
42. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-1147.
43. Wright DL, Jones EL, Mayer JF, Oehninger S, Gibbons WE, Lanzendorf SE. Characterization of telomerase activity in the human oocyte and preimplantation embryo. Mol. Hum. Reprod. 2001; 7: 947-955.
44. Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood. 1998; 91: 3255-3262.
45. Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000; 28: 4474-4478.
46. Hathcock KS, Hemann MT, Opperman KK, Strong MA, Greider CW, Hodes RJ. Haploinsufficiency of mTR results in defects in telomere elongation. Proc. Natl. Acad. Sci. USA 2002; 99: 3591-3596.
47. Rastinejad F, Blau HM. Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation. Cell. 1993; 72: 903-917.
48. Rastinejad F, Conboy MJ, Rando TA, Blau HM. Tumor suppression by RNA from the 3' untranslated region of alpha-tropomyosin. Cell. 1993; 75: 1107-1117.
49. Taulli R, Scuoppo C, Bersani F, Accornero P, Forni PE, Miretti S, Grinza A, Allegra P, Schmitt-Ney M, Crepaldi T, Ponzetto C. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res. 2006; 66: 4742-4749.
50. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977; 270: 725-727.
51. Okabe J, Eguchi A, Masago A, Hayakawa T, Nakanishi M. TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells. Hum. Mol. Genet. 2000; 9: 2639-2650.
52. Robertson TA, Grounds MD, Mitchell CA, Papadimitriou JM. Fusion between myogenic cells in vivo: an ultrastructural study in regenerating murine skeletal muscle. J. Struct. Biol. 1990; 105 (1-3): 170-182.
53. Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell. 2007; 6: 515-523.
54. Di Donna S, Mamchaoui K, Cooper RN, Seigneurin-Venin S, Tremblay J, Butler-Browne GS, Mouly V. Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol. Cancer Res. 2003; 1: 643-653.
55. Shay JW, Wright WE. Use of telomerase to create bioengineered tissues. Ann. NY. Acad. Sci. 2005; 1057: 479-491.
56. Coviello-McLaughlin GM, Prowse KR. Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res. 1997; 25: 3051-3058.
57. Decary S, Hamida CB, Mouly V, Barbet JP, Hentati F, Butler-Browne GS. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 2000; 10: 113-120.